Discontinuation of tyrosine kinase inhibitors in pediatric chronic myeloid leukemia.
Shima H, Kada A, Tanizawa A, Sato I, Tono C, Ito M, Yuza Y, Watanabe A, Kamibeppu K, Uryu H, Koh K, Imai C, Yoshida N, Koga Y, Fujita N, Saito AM, Adachi S, Ishii E, Shimada H.
Shima H, et al. Among authors: watanabe a.
Pediatr Blood Cancer. 2022 Aug;69(8):e29699. doi: 10.1002/pbc.29699. Epub 2022 Apr 11.
Pediatr Blood Cancer. 2022.
PMID: 35403816